Skip to main content
OpenTrials
Completed

NCT Number: NCT05101811

Vitamin D Levels in Women With Polycystic Ovary Syndrome

Polycystic ovary syndrome is the commonest endocrinopathy among women of reproductive age. Its worldwide prevalence has been estimated between5-10%.

Vitamin D, a fat-soluble vitamin, can be produced in two ways: by intestinal absorption and endogenous synthesis from a precursor of 17-hydroxyl cholesterol on the skin with sufficient exposure to ultraviolet sunlight.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Polycystic Ovary Syndrome Adnexal Diseases Cysts Endocrine System Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Female Gonadal Disorders Neoplasms Ovarian Cysts Ovarian Diseases Urogenital Diseases

Age range

18 year–35 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

Misr Al Gadida Military hospital

Cairo, 11311, Egypt

About this study

The aim of this work is assessment of the level of vitamin D in female have polycystic ovary syndrome & healthy female.and also make diagnostic criteria for patient who is in need for supplementations with vitamin D.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Hyperandrogenism
  • Polycystic ovary syndrome

Exclusion criteria

  • Thyroid disease
  • Parathyroid disease
  • Diabetes Mellitus
  • Cushing syndrome
  • Congenital adrenal hyperplasia
  • Hyperprolactinemia
  • Renal, liver or chronic disease

Treatment and study plan

Vitamin D Levels measurement using chemiluminescent assay

Drug

Measurement of serum vitamin D levels

Vitamin D level assessment

Device

Using lIAISON DEVICE

Primary outcomes

  1. Levels of vitamin D in Polycystic ovary syndrome

    Time frame: 1 year

    vitamin D levels is assumed to be significantly decreased

Secondary outcomes

  1. Levels of vitamin D in fertile women

    Time frame: 1 year

    vitamin D level is expected to be normal

Sponsors and collaborators

Lead sponsor

Ghamra Military Hospital

Other

Collaborators

  • Al-Azhar University

Registry information

Official study title

Assessment of Serum Vitamin D Levels in Women With Polycystic Ovary Syndrome

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Nov 1, 2021
Registry last updated
Nov 1, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.